WALL, NJ--(Marketwired - Jul 19, 2017) - BIO-key International, Inc. (
"BIO-key is achieving particularly strong sales traction in healthcare, expanding beyond our initial success with large hospital customers. This growth is being driven by regulatory compliance and supported by the workplace convenience that fingerprint biometrics provide," stated Mike DePasquale, Chairman & CEO, BIO-key.
"Saving healthcare professionals precious minutes each day is good for patient care and the bottom line."
Mr. DePasquale added, "We are finding that end users, such as nurses, physicians and administrators, genuinely appreciate the ease of one touch biometric authentication versus the frustration associated with other sign-in methods. Because professionals in highly regulated industries such as healthcare are required to use multifactor authentication dozens of times per day, BIO-key is emerging as 'the' ideal solution to meet this requirement while also enhancing workflow efficiency. Saving healthcare professionals precious minutes each day is good for patient care and the bottom line."
About BIO-key International, Inc. ( www.bio-key.com ) BIO-key is revolutionizing authentication with biometric solutions that enable convenient and secure access to information and secure high-stakes transactions. We offer alternatives to passwords, PINs, tokens and cards to make it easy for enterprises and consumers to secure their devices as well as information in the cloud. Our premium finger scanning devices, including SideSwipe , SideTouch , EcoID as well as SidePass, offer market-leading quality, performance and price. Now you can BIO-key your world!
BIO-key Safe Harbor Statement Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, market acceptance of biometric solutions generally and our specific offerings, our ability to expand into the Asian market, the impact on our business of the recent financial crisis in the global capital markets, and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2016 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made.
Twitter: BIO-keyIR
Investor & Media Contacts David Collins William Jones Tanya Kamatu Catalyst Global 212-924-9800 bkyi@catalyst-ir.com
